Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-14 06:07 am Purchase | 2021-12-31 | 13G | Xilio Therapeutics, Inc. XLO | Takeda Pharmaceutical Company Limited | 1,475,121 5.370% | 1,475,121 (New Position) | Filing History |
| 2022-01-14 06:06 am Sale | 2021-12-31 | 13G | Shattuck Labs, Inc. STTK | Takeda Pharmaceutical Company Limited | 2,090,858 4.950% | -9,454 (-0.45%) | Filing History |
| 2022-01-14 06:02 am Purchase | 2021-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | Takeda Pharmaceutical Company Limited | 6,012,758 9.700% | 6,012,758 (New Position) | Filing History |
| 2021-11-12 06:03 am Sale | 2021-11-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Takeda Pharmaceutical Company Limited | 7,459,304 19.200% | -1,212,696 (-13.98%) | Filing History |
| 2021-10-25 06:07 am Sale | 2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Takeda Pharmaceutical Company Limited | 530,562 1.700% | -1,328,589 (-71.46%) | Filing History |
| 2021-10-18 06:03 am Sale | 2021-10-14 | 13G | BiomX Inc. PHGE | Takeda Pharmaceutical Company Limited | 147,829 5.200% | -99,265 (-40.17%) | Filing History |
| 2021-09-14 06:13 am Sale | 2021-08-24 | 13D | Molecular Templates, Inc. MTEM | Takeda Pharmaceutical Company Limited | 154,311 4.100% | -40,556 (-20.81%) | Filing History |
| 2021-08-30 06:07 am Purchase | 2021-07-22 | 13G | HOOKIPA Pharma Inc. HOOK | Takeda Pharmaceutical Company Limited | 29,069 1.100% | 29,069 (New Position) | Filing History |
| 2021-04-06 06:05 am Unchanged | 2021-04-02 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Takeda Pharmaceutical Company Limited | 8,672,000 22.300% | 0 (Unchanged) | Filing History |
| 2021-04-01 06:06 am Unchanged | 2021-03-31 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Takeda Pharmaceutical Company Limited | 8,672,000 22.300% | 0 (Unchanged) | Filing History |
| 2021-02-05 06:10 am Purchase | 2020-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK | Sumitomo Mitsui Trust Group, Inc. | 94,034,034 6.000% | 94,034,034 (New Position) | Filing History |
| 2021-02-01 08:17 am Sale | 2020-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK | BlackRock Inc. BLK | 99,548,936 6.300% | -1,779,055 (-1.76%) | Filing |
| 2021-01-29 06:06 am Purchase | 2020-12-31 | 13G | Shattuck Labs, Inc. STTK | Takeda Pharmaceutical Company Limited | 2,100,312 5.060% | 2,100,312 (New Position) | Filing History |
| 2021-01-28 5:57 pm Purchase | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | Takeda Pharmaceutical Company Limited | 87,258 0.300% | 87,258 (New Position) | Filing History |
| 2021-01-27 06:02 am Unchanged | 2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Takeda Pharmaceutical Company Limited | 1,859,151 7.200% | 0 (Unchanged) | Filing History |
| 2021-01-25 06:07 am Sale | 2020-12-31 | 13G | Telesis Bio, Inc. TBIO | Takeda Pharmaceutical Company Limited | 0 0.000% | -393,275 (Position Closed) | Filing History |